Drug discovery: Estrogen-related compounds in mouse models of Alzheimer’s disease

Author： Smith Jonathan Chakrabarti Enakshi Levin-Allerhand Justine

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.24, Iss.1, 2004-02, pp. : 145-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug discovery for Alzheimer’s disease: The end of the beginning

By Refolo Lorenzo Fillit Howard

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 1-8

Humana Press, Inc

Access to resources Recommend Favorite

Novel approaches to models of Alzheimer’s disease pathology for drug screening and development

By Shaughnessy Laura Chamblin Beth McMahon Lori Nair Ayyappan Thomas Mary Wakefield John Koentgen Frank Ramabhadran Ram

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 23-32

Humana Press, Inc

Access to resources Recommend Favorite

Validation of the Neuroinflammation Cycle as a Drug Discovery Target Using Integrative Chemical Biology and Lead Compound Development with an Alzheimer's Disease-Related Mouse Model

Current Alzheimer Research, Vol. 2, Iss. 2, 2005-04 ,pp. : 197-205

Bentham Science Publishers

Access to resources Recommend Favorite

Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite

Biomarkers to advance drug development for Alzheimer’s disease

By Schulman Howard

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 409-415

Future Medicine

Access to resources Recommend Favorite